Enanta Pharmaceuticals, Inc. (ENTA)
NASDAQ: ENTA · Real-Time Price · USD
12.01
-0.36 (-2.91%)
Oct 8, 2026, 11:11 AM EDT - Market open
Enanta Pharmaceuticals Market Cap
Enanta Pharmaceuticals has a market cap or net worth of $349.8 million as of October 8, 2026. It is the 17,169th most valuable company in the world and the 3,027th biggest in the United States. Its market cap has increased by 47.66% in one year.
Market Cap
349.80M
Enterprise Value
320.34M
1-Year Change
47.66%
Global Rank
Country Rank
#3,027 United States
Category
ChartMarket Cap Chart
Since March 21, 2013, Enanta Pharmaceuticals's market cap has increased from $289.30M to $349.80M, an increase of 20.91%. That is a compound annual growth rate of 1.41%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2026 | 349.80M | -23.16% |
| Dec 31, 2025 | 455.20M | 273.42% |
| Dec 31, 2024 | 121.90M | -38.50% |
| Dec 29, 2023 | 198.20M | -79.51% |
| Dec 30, 2022 | 967.50M | -36.34% |
| Dec 31, 2021 | 1.52B | 79.81% |
| Dec 31, 2020 | 845.30M | -30.63% |
| Dec 31, 2019 | 1.22B | -11.43% |
| Dec 31, 2018 | 1.38B | 22.59% |
| Dec 29, 2017 | 1.12B | 75.96% |
| Dec 30, 2016 | 637.80M | 2.77% |
| Dec 31, 2015 | 620.60M | -34.40% |
| Dec 31, 2014 | 946.00M | 93.06% |
| Dec 31, 2013 | 490.00M | 69.37% |
| Mar 21, 2013 | 289.30M | - |
View and export this data all the way back to 2013. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Opus Genetics | 380.20M |
| Arcturus Therapeutics Holdings | 378.31M |
| Fennec Pharmaceuticals | 365.05M |
| Inhibikase Therapeutics | 362.33M |
| C4 Therapeutics | 360.46M |
| Turn Therapeutics | 355.07M |
| Relmada Therapeutics | 354.14M |
| Artiva Biotherapeutics | 350.54M |